Management of first trimester spontaneous abortion with 800 or 400 microg vaginal misoprostol. 2006

T S Vejborg, and C Rørbye, and L Nilas
Department of Obstetrics and Gynecology, H:S Hvidovre Hospital, University of Copenhagen, Denmark.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000020 Abortifacient Agents, Nonsteroidal Non-steroidal chemical compounds with abortifacient activity. Abortifacient Agents, Non-Steroidal,Abortifacient Agents, Non Steroidal,Agents, Non-Steroidal Abortifacient,Agents, Nonsteroidal Abortifacient,Non-Steroidal Abortifacient Agents,Nonsteroidal Abortifacient Agents

Related Publications

T S Vejborg, and C Rørbye, and L Nilas
July 2004, Contraception,
T S Vejborg, and C Rørbye, and L Nilas
December 2005, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception,
T S Vejborg, and C Rørbye, and L Nilas
February 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
T S Vejborg, and C Rørbye, and L Nilas
October 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
T S Vejborg, and C Rørbye, and L Nilas
June 2003, Contraception,
T S Vejborg, and C Rørbye, and L Nilas
November 2005, Acta obstetricia et gynecologica Scandinavica,
T S Vejborg, and C Rørbye, and L Nilas
May 2001, Contraception,
T S Vejborg, and C Rørbye, and L Nilas
October 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
T S Vejborg, and C Rørbye, and L Nilas
May 1998, Contraception,
Copied contents to your clipboard!